Reactions Weekly

, Volume 1695, Issue 1, pp 323–323 | Cite as

Rituximab

Interstitial lung disease: 2 case reports
Case report
First Online:
  • 12 Downloads
This is a preview of subscription content, log in to check access

Reference

  1. Park SY, et al. Pneumocystis pneumonia versus rituximab-induced interstitial lung disease in lymphoma patients receiving rituximab-containing chemotherapy. Medical Mycology 55: 349-357, No. 4, Jun 2017. Available from: URL: http://doi.org/10.1093/mmy/myw095 - South KoreaPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations